CTRI/2018/04/013089已完成未知
A study on Japanese Encephalitis and other Acute Encephalitis Syndrome in the district Khurda, Odisha, India.
ikita Raula0 个研究点目标入组 39 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 39
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Males/ Females 0 to 15 years, who are falling into the case definition and where consent could be obtained.
排除标准
- •Those who are NOT willing to give consent Males/ Females 0 to 15years
研究者
相似试验
尚未招募
3 期
ong Term Immunogenicity of the JE Vaccine IC51Prophylactic Vaccine against Japanese EncephalitisNeurological - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12605000681651Intercell AG600
尚未招募
不适用
Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis VirusJapanese EncephalitisNCT06674837ANRS, Emerging Infectious Diseases4,000
已完成
3 期
A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese InfantsEncephalitisNCT02367664Jiangsu Province Centers for Disease Control and Prevention900
尚未招募
3 期
Safety and Tolerability Study of the JE Vaccine IC51Prophylactic Vaccine against Japanese EncephalitisNeurological - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12605000680662Intercell AG600
进行中（未招募）
不适用
Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302Japanese encephalitis (JE) is the most common viral encephalitis, with over 50,000 cases reported annually. It is a considerable public health problem for many Asian countries (WHO 1997). Close to 3 billion people now live in regions at risk for the disease, particularly in rural areas where JE occurs sporadically in epidemics of variable magnitude. Vaccination against JE remains the single most important control measure worldwide.EUCTR2005-000100-14-DEIntercell AG2,680